Kevin J. Gilligan, PhD

Kevin J. Gilligan, PhD

Senior Consultant

Dr. Kevin J. Gilligan is a virologist and emerging disease subject matter expert with over 30 years of experience in the research and development of vaccines, therapeutics and diagnostics that address public health needs. As a National Research Council Fellow at the United States Army Medical Research Institute for Infectious Disease (USAMRIID), Dr. Gilligan developed the first prototype that induced protective immunity against a lethal challenge of Ebola infection. Following that, Dr. Gilligan and his team at Bayer Blood Products Division developed the 1st practical assay for measuring prion infectivity in blood products such as IGIV and Factor VIII. Dr. Gilligan served for 9 years as Unit Chief and Project Officer in Pandemic Influenza at HHS/BARDA, supporting the development of drugs, vaccines and diagnostics as emergency countermeasures. Under his leadership, the contract to develop IV peramivir to treat influenza infection resulted in an FDA approval in December of 2014, under the brand name Rapivab®.

Since 2015, Dr. Gilligan has operated his own consulting company, helping small and medium size R&D companies acquire funding and conduct clinical trials for drugs and vaccines against a variety of emerging diseases, including influenza, Zika, filoviruses and alphaviruses.

Dr. Gilligan has published many scientific papers, abstracts and review articles in scientific journals devoted to virology, infectious disease, and drug development and is a recognized subject matter expert in such areas as molecular virology, vaccine development, antiviral drugs and therapeutics, clinical study and endpoint design, government contracting and source selection and proposal writing.

Dr. Gilligan received a BA in Biology from Salem University in 1979, and after graduate work at Harvard University in Biochemistry, received a Ph.D. in Microbiology and Immunology from the University of North Carolina-Chapel Hill in 1990.


PhD, Microbiology and Immunology, University of North Carolina – Chapel Hill, Chapel Hill, NC (1990)

Graduate work in Biochemistry, Harvard University, Cambridge, MA (1984)

BA, Biology, Salem State College, Salem, MA (1979)